These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 25666511)

  • 1. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
    Aras LM; Isla J; Mingorance-Le Meur A
    Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
    De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
    Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Myers KA; Lightfoot P; Patil SG; Cross JH; Scheffer IE
    Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
    Buck ML; Goodkin HP
    Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
    Cao D; Ohtani H; Ogiwara I; Ohtani S; Takahashi Y; Yamakawa K; Inoue Y
    Epilepsia; 2012 Jul; 53(7):1140-5. PubMed ID: 22578034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.
    Chiron C; Marchand MC; Tran A; Rey E; d'Athis P; Vincent J; Dulac O; Pons G
    Lancet; 2000 Nov; 356(9242):1638-42. PubMed ID: 11089822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dravet syndrome is a rare genetic epileptic disorder that can be mistaken for fever cramps].
    Johannesen KM; Hansen MB
    Ugeskr Laeger; 2014 Mar; 176(14):. PubMed ID: 25350058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
    Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
    Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit of use of stiripentol in adults with Dravet syndrome.
    Balestrini S; Sisodiya SM
    Acta Neurol Scand; 2017 Jan; 135(1):73-79. PubMed ID: 27231140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    Trivisano M; Specchio N; Vigevano F
    Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.
    Nabbout R; Mistry A; Zuberi S; Villeneuve N; Gil-Nagel A; Sanchez-Carpintero R; Stephani U; Laux L; Wirrell E; Knupp K; Chiron C; Farfel G; Galer BS; Morrison G; Lock M; Agarwal A; Auvin S;
    JAMA Neurol; 2020 Mar; 77(3):300-308. PubMed ID: 31790543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dravet syndrome, what is new?
    Al-Baradie RS
    Neurosciences (Riyadh); 2013 Jan; 18(1):11-7. PubMed ID: 23291792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.